Angelini Ventures invests in a $39 million Series A extension round for Therini Bio, advancing treatments for neurodegenerative diseases. This round brings total funding to $75 million.
Amount Raised
$39 Million
Round Type
Series A
SacramentoBiotechnologyInvestors
Description
Angelini Ventures participates in a $39 million extension of Therini Bio's Series A financing round, aimed at developing fibrin-targeting immunotherapies for neurodegenerative diseases. The investment will fund Phase 1b studies for the lead candidate, THN391, targeting Alzheimer's Disease and Diabetic Macular Edema. The total raised in this Series A round now stands at $75 million, with participation from top-tier investors including Apollo Health Ventures and SV Health Investors.
Quick answer
Therini Bio raised $39 Million in a Series A round, dated May 14, 2025. Investors: Sanofi Ventures, MRL Ventures Fund, Foundation For A Better World, Eli Lilly And Company, Dolby Family Ventures, Dementia Discovery Fund, Sv Health Investors' Biotech Fund and Apollo Health Ventures. Therini Bio is based in Sacramento, California, United States.
- How much did Therini Bio raise?
- Therini Bio raised $39 Million in a Series A round on May 14, 2025.
- Who invested in Therini Bio?
- Sanofi Ventures, MRL Ventures Fund, Foundation For A Better World, Eli Lilly And Company, Dolby Family Ventures, Dementia Discovery Fund, Sv Health Investors' Biotech Fund and Apollo Health Ventures are named as investors in this round.
- What does Therini Bio do?
- Therini Bio, Inc. is a biotechnology company dedicated to the research and development of novel therapeutics for the treatment of neuroinflammatory diseases due to vascular dysfunction.
- Where is Therini Bio based and how big is it?
- Therini Bio is based in Sacramento, California, United States. Fundz records about 10 employees.
- Who are the decision-makers at Therini Bio?
- Fundz holds 2 contacts at Therini Bio. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology around the same time
Companies in the same sectors as Therini Bio that raised within 45 days of this round, from Fundz verified event records.
- Biofrontera raised $11M on June 27, 2025.
- Juvena Therapeutics raised $30M on June 27, 2025.
- NewcelX raised $1M (Seed) on June 27, 2025.
- Gallant raised $10M on June 27, 2025.
- Abvance Therapeutics raised an undisclosed amount (Seed) on June 27, 2025.
- Juniper Genomics raised $4.6M (Seed) on June 26, 2025.
Who to call at Therini Bio, and when
A new round usually means Therini Bio is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Therini Bio raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Therini Bio, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Therini Bio. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Therini Bio raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansTherini Bio raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.